WINSTON-SALEM, NC--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it will report financial results for the third quarter ended September 30, 2010 on Thursday, November 4, 2010, after the U.S. financial markets close.
